公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2011 | Depletion of β-catenin from mature hepatocytes of mice promotes expansion of hepatic progenitor cells and tumor development | Wang E.-Y.; Shiou-Hwei Yeh ; Tsai T.-F.; HSIANG-PO HUANG ; YUNG-MING JENG ; Lin W.-H.; Chen W.-C.; KUN-HUEI YEH ; PEI-JER CHEN ; Chen D.-S. | Proceedings of the National Academy of Sciences of the United States of America | 30 | 26 | |
1997 | Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/NeuroD-deficient mice | Naya F.J.; HSIANG-PO HUANG ; Qiu Y.; Mutoh H.; DeMayo F.J.; Leiter A.B.; Tsai M.-J. | Genes and Development | 879 | 801 | |
2005 | Differential integration rates of hepatitis B virus DNA in the liver of children with chronic hepatitis B virus infection and hepatocellular carcinoma | HSIANG-PO HUANG ; Tsuei D.-J.; Wang K.-J.; Chen Y.-L.; YEN-HSUAN NI ; YUNG-MING JENG ; HUEY-LING CHEN ; HONG-YUAN HSU ; YING-LIEN CHEN | Journal of Gastroenterology and Hepatology (Australia) | 8 | 7 | |
2014 | Discovery of novel src homology region 2 domain-containing phosphatase 1 agonists from sorafenib for the treatment of hepatocellular carcinoma | Tai W.-T.; Shiau C.-W.; PEI-JER CHEN ; Chu P.-Y.; HSIANG-PO HUANG ; Liu C.-Y.; Huang J.-W.; Chen K.-F. | Hepatology | 63 | 59 | |
2010 | Distinct hepatitis B virus dynamics in the immunotolerant and early immunoclearance phases | HURNG-YI WANG ; Chien M.-H.; HSIANG-PO HUANG ; Chang H.-C.; Wu C.-C.; PEI-JER CHEN ; MEI-HWEI CHANG ; Chen D.-S. | Journal of Virology | 75 | 71 | |
2011 | Epithelial cell adhesion molecule (EpCAM) complex proteins promote transcription factor-mediated pluripotency reprogramming | HSIANG-PO HUANG ; Chen P.-H.; Yu C.-Y.; Chuang C.-Y.; Stone L.; Hsiao W.-C.; Li C.-L.; Tsai S.-C.; Chen K.-Y.; HSIN-FU CHEN ; HONG-NERNG HO ; Kuo H.-C. | Journal of Biological Chemistry | 74 | 71 | |
2009 | Eye anomalies and neurological manifestations in patients with PAX6 mutations. | YIN-HSIU CHIEN ; HSIANG-PO HUANG ; WUH-LIANG HWU ; Chien Y.H.; Chang T.C.; NI-CHUNG LEE | Molecular vision | 26 | 19 | |
2010 | Factors from human embryonic stem cell-derived fibroblast-like cells promote topology-dependent hepatic differentiation in primate embryonic and induced pluripotent stem cells | HSIANG-PO HUANG ; Yu C.-Y.; HSIN-FU CHEN ; Chen P.-H.; Chuang C.-Y.; SUNG-JAN LIN ; Huang S.-T.; Chan W.-H.; Ueng T.-H.; HONG-NERNG HO ; Kuod H.-C. | Journal of Biological Chemistry | 24 | 22 | |
2011 | Gene targeting and expression analysis of mouse Tem1/endosialin using a lacZ reporter | HSIANG-PO HUANG ; Hong C.-L.; Kao C.-Y.; SHU-WHA LIN ; Lin S.-R.; Wu H.-L.; Shi G.-Y.; You L.-R.; Wu C.-L.; Yu I.-S. | Gene Expression Patterns | 25 | 19 | |
1996 | Gene therapy for hepatocellular carcinoma: Long-term remission of primary and metastatic tumors in mice by interleukin-2 gene therapy in vivo | HSIANG-PO HUANG ; Chen S.H.; Kosai K.; Finegold M.J.; Woo S.L.C. | Gene Therapy | 73 | 71 | |
2015 | Granulosa cell-derived induced pluripotent stem cells exhibit pro-Trophoblastic differentiation potential | Chuang C.-Y.; Huang M.-C.; HSIN-FU CHEN ; LI-HUI TSENG ; Yu C.-Y.; Stone L.; HSIANG-PO HUANG ; HONG-NERNG HO ; Kuo H.-C. | Stem Cell Research and Therapy | 11 | 9 | |
2019 | HAI-2 as a novel inhibitor of plasmin represses lung cancer cell invasion and metastasis | Wu S.-R.; Lin C.-H.; Shih H.-P.; Chun-Jung Ko ; Lin H.-Y.; Lan S.-W.; Lin H.-H.; Tu H.-F.; CHAO-CHI HO ; HSIANG-PO HUANG ; MING-SHYUE LEE | British Journal of Cancer | 8 | 9 | |
2014 | HAI-2 suppresses the invasive growth and metastasis of prostate cancer through regulation of matriptase | Tsai C.-H.; Teng C.-H.; Tu Y.-T.; Cheng T.-S.; Wu S.-R.; Chun-Jung Ko ; Shyu H.-Y.; Lan S.-W.; HSIANG-PO HUANG ; Tzeng S.-F.; Johnson M.D.; Lin C.-Y.; Hsiao P.-W.; MING-SHYUE LEE | Oncogene | 47 | 42 | |
2011 | Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification | HSIANG-PO HUANG ; Chen P.-H.; WUH-LIANG HWU ; Chuang C.-Y.; YIN-HSIU CHIEN ; Stone L.; CHUNG-LIANG CHIEN ; Li L.-T.; Chiang S.-C.; HSIN-FU CHEN ; HONG-NERNG HO ; Chen C.-H.; Kuo H.-C. | Human Molecular Genetics | 111 | 105 | |
2012 | Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification (vol 20, pg 4851, 2011) | HSIANG-PO HUANG ; Chen, PH; WUH-LIANG HWU; Chuang, CY; YIN-HSIU CHIEN ; Stone, L; CHUNG-LIANG CHIEN ; Li, LT; Chiang, SC; HSIN-FU CHEN ; HONG-NERNG HO ; Chen, CH; Kuo, HC | HUMAN MOLECULAR GENETICS | 0 | 0 | |
2012 | Induced pluripotent stem cell technology for disease modeling and drug screening with emphasis on lysosomal storage diseases | HSIANG-PO HUANG ; Chuang C.-Y.; Kuo H.-C. | Stem Cell Research and Therapy | 17 | 13 | |
2022 | An induced pluripotent stem cell-based model identifies molecular targets of vincristine neurotoxicity | Tsai, Neng-Wei; Lin, Cheng-Chen; Yeh, Ti-Yen; Chiu, Yu-An; Chiu, Hsin-Hui; HSIANG-PO HUANG ; SUNG-TSANG HSIEH | Disease models & mechanisms | 0 | 0 | |
2018 | Induced pluripotent stem cell-derived endothelial progenitor cells attenuate ischemic acute kidney injury and cardiac dysfunction | Shen W.-C.; YU-HSIANG CHOU ; HSIANG-PO HUANG ; Sheen J.-F.; Hung S.-C.; HSIN-FU CHEN | Stem Cell Research and Therapy | 27 | 27 | |
2017 | Inhibition of cyclooxygenase-2-mediated matriptase activation contributes to the suppression of prostate cancer cell motility and metastasis | Chun-Jung Ko ; Lan S.-W.; YU-CHUAN LU ; Cheng T.-S.; Lai P.-F.; Tsai C.-H.; Hsu T.-W.; Lin H.-Y.; Shyu H.-Y.; Wu S.-R.; Lin H.-H.; Hsiao P.-W.; CHUNG-HSIN CHEN ; HSIANG-PO HUANG ; MING-SHYUE LEE | Oncogene | 38 | 32 | |
2020 | Inhibition of TMPRSS2 by HAI-2 reduces prostate cancer cell invasion and metastasis | Chun-Jung Ko ; Hsu, Ting-Wei; Wu, Shang-Ru; Lan, Shao-Wei; Hsiao, Ting-Feng; Lin, Hsin-Ying; Lin, Hsin-Hsien; Tu, Hsin-Fang; Lee, Cheng-Fan; Huang, Cheng-Chung; Chen, Mei-Ju May; Hsiao, Pei-Wen; HSIANG-PO HUANG ; MING-SHYUE LEE | Oncogene | 28 | 25 | |